Marie Okubo Yuji Hataya Kanta Fujimoto Toshio Iwakura Naoki Matsuoka
10.1111/jdi.13927
J Diabetes Investig
2023 Jan;14(1):147-150.
immune checkpoint inhibitor-associated diabetes mellitus immune-related adverse event
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36251515/
Antineoplastic Agents, Immunological / adverse effects Diabetes Mellitus Lung Neoplasms / complications Lung Neoplasms / drug therapy
Antineoplastic Agents, Immunological / adverse effects Diabetes Mellitus Lung Neoplasms / complications Lung Neoplasms / drug therapy Case Reports Glucagon Humans Immune Checkpoint Inhibitors / adverse effects Insulin / therapeutic use Male Middle Aged Immune Checkpoint Inhibitors Antineoplastic Agents, Immunological Insulin Glucagon
PMC9807149
36251515
Recovery from insulin dependence in immune checkpoint inhibitor-associated diabetes mellitus: A case report
2023